Dual-Drug Nanostructured Lipid Carriers of Spironolactone and 2-Deoxy-D-Ribose for Targeted Follicular Delivery in Androgenetic Alopecia
May 2026
in “
Drug Delivery and Translational Research
”
Studysummary Nanocarriers with spironolactone and 2-deoxy-D-ribose may improve hair loss treatment by targeting hair follicles directly.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on link.springer.com →